UNICA IRIS Institutional Research Information System

PISTIS, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 197.222
NA - Nord America 8.684
AS - Asia 4.203
SA - Sud America 658
AF - Africa 113
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 10
Totale 210.901
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 194.930
US - Stati Uniti d'America 8.553
SG - Singapore 1.670
CN - Cina 1.427
SE - Svezia 585
UA - Ucraina 552
BR - Brasile 499
VN - Vietnam 379
DE - Germania 267
FI - Finlandia 221
GB - Regno Unito 220
FR - Francia 214
HK - Hong Kong 180
IN - India 104
KR - Corea 81
CA - Canada 75
AR - Argentina 54
IQ - Iraq 52
BD - Bangladesh 49
NL - Olanda 44
TR - Turchia 41
PL - Polonia 35
AT - Austria 31
ZA - Sudafrica 31
MX - Messico 30
JP - Giappone 27
PK - Pakistan 25
ES - Italia 24
UZ - Uzbekistan 24
RU - Federazione Russa 23
CO - Colombia 21
MA - Marocco 21
ID - Indonesia 20
VE - Venezuela 19
EC - Ecuador 18
CL - Cile 16
SA - Arabia Saudita 16
PH - Filippine 15
IL - Israele 14
BE - Belgio 13
EG - Egitto 13
IE - Irlanda 12
PY - Paraguay 12
CZ - Repubblica Ceca 11
KE - Kenya 10
TN - Tunisia 10
EU - Europa 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
CH - Svizzera 8
PE - Perù 8
BO - Bolivia 7
CR - Costa Rica 7
JO - Giordania 7
AU - Australia 6
DO - Repubblica Dominicana 6
IR - Iran 6
LT - Lituania 6
MY - Malesia 6
NP - Nepal 6
ET - Etiopia 5
JM - Giamaica 5
OM - Oman 5
DZ - Algeria 4
HN - Honduras 4
KZ - Kazakistan 4
TH - Thailandia 4
AL - Albania 3
CI - Costa d'Avorio 3
GR - Grecia 3
KG - Kirghizistan 3
LB - Libano 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
BG - Bulgaria 2
CY - Cipro 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LY - Libia 2
MU - Mauritius 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BJ - Benin 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
Totale 210.884
Salva come PNG Salva come JPEG
Città #
Cagliari 190.541
Uta 3.894
Fairfield 915
Singapore 826
Ashburn 781
Woodbridge 641
San Jose 517
Chandler 435
Houston 416
Boardman 398
Dallas 387
Ann Arbor 383
Seattle 340
Nyköping 339
Wilmington 338
Cambridge 301
Jacksonville 267
Beijing 257
Dearborn 194
Los Angeles 179
Hong Kong 163
Helsinki 138
Santa Clara 137
Shanghai 132
New York 122
Ho Chi Minh City 121
Council Bluffs 115
Hefei 115
Lauterbourg 115
Nanjing 107
Boston 94
Seoul 79
Hanoi 72
The Dalles 67
Buffalo 66
San Diego 53
Guangzhou 49
Dong Ket 46
São Paulo 45
Milan 43
Frankfurt am Main 39
Munich 39
Nanchang 39
London 38
Rome 34
Hebei 32
Shenyang 32
Warsaw 31
Chicago 30
Orem 29
Redwood City 29
Redondo Beach 28
Tianjin 27
Baghdad 25
Mountain View 24
Jiaxing 22
Tokyo 22
Vienna 22
Nuremberg 21
Tashkent 21
Toronto 20
Jinan 19
Da Nang 18
Norwalk 18
Atlanta 17
Denver 17
Brooklyn 16
Changsha 16
Kunming 16
Montreal 16
San Francisco 16
Chennai 15
Johannesburg 15
Washington 15
Haiphong 14
Amsterdam 13
Brussels 13
Phoenix 13
Porto Alegre 13
Verona 13
Auburn Hills 12
Augusta 12
Dublin 12
Orange 12
San Mateo 12
Sèlegas 12
Casablanca 11
Mexico City 11
Taizhou 11
Zhengzhou 11
New Delhi 10
Poplar 10
Quito 10
Rio de Janeiro 10
Santiago 10
Sassari 10
Shenzhen 10
Stockholm 10
Wuhan 10
Biên Hòa 9
Totale 205.340
Salva come PNG Salva come JPEG
Nome #
Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain 37.757
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. 4.627
Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in sardinian alcohol-preferring rats 4.168
Maternal immune activation disrupts dopamine system in the offspring 4.145
Ester of a phospholipid with conjugated linoleic acid for the treatment of psychiatric disorders with neuroinflammatory and neurodegenerative basis 3.473
Adolescent Δ 9-Tetrahydrocannabinol exposure alters WIN55,212-2 self-administration in adult rats 3.371
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.353
Physiological role of peroxisome proliferator-activated receptors type alpha on dopamine systems 3.088
Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling 3.018
null 2.940
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward 2.819
Endocannabinoid signaling in motivation, reward, and addiction: influences on mesocorticolimbic dopamine function 2.736
The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia 2.716
Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells 2.589
Astrocytic Mechanisms Involving Kynurenic Acid Control Δ9-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas 2.538
null 2.498
Effects of maternal immune activation on dopamine activity in male and female offspring 2.458
PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors 2.452
null 2.394
Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats 2.369
PPAR-alpha: a new target for the treatment of nocturnal frontal lobe epilepsy 2.350
Inhibitory inputs from rostromedial tegmental nucleus regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse 2.306
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors 2.227
Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: Therapeutic perspectives 2.176
Alcohol inhibits spontaneous activity of basolateral amygdala projection neurons in the rat: Involvement of the endocannabinoid system 2.166
Trattamenti farmacologici per la dipendenza da nicotina 2.045
Δ9-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation 2.013
Dynamic interactions between drugs of abuse and the endocannabinoid system: molecular mechanisms and functional outcome 2.003
Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (S)-CE-123 on Mesocorticolimbic Dopamine System 1.999
The role of nuclear hormone receptors in cannabinoid function 1.951
Pharmacological treatments for nicotine dependence 1.910
Opposite responses to aversive stimuli in lateral habenula neurons 1.903
Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. 1.855
Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-α nuclear receptors 1.854
Exposure to tobacco smoke during the early postnatal period modifies receptors and enzymes of the endocannabinoid system in the brainstem and striatum in mice 1.821
Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2 1.817
Cannabinoid withdrawal: where does the hypodopaminergic state come from? 1.805
Neurobiologia della dipendenza da nicotina 1.794
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid 1.793
Roles of N-acylethanolamines in brain functions and neuropsychiatric diseases 1.783
ENDOCANNABINOID-MEDIATED PLASTICITY AT INHIBITORY SYNAPSES ONTO DOPAMINE NEURONS AS A POSSIBLE MARKER OF INNATE PREFERENCE TO ALCOHOL 1.775
The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding 1.761
Characterization of wild-type (R100R) and mutated (Q100Q) GABA(A) alpha(6) subunit in Sardinian alcohol non-preferring rats (sNP) 1.753
Neurobiology of nicotine addiction 1.676
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.662
Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex 1.623
Preclinical studies of cannabis addiction − relationships between the endocannabinoid and dopamine systems 1.603
Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings 1.598
Environmental Tobacco Smoke During the Early Postnatal Period of Mice Interferes With Brain 18 F-FDG Uptake From Infancy to Early Adulthood – A Longitudinal Study 1.572
Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features and emerging specificities of the two major endocannabinoids 1.570
The endocannabinoid system and nondrug rewarding behaviours 1.455
Hub and switches: endocannabinoid signalling in midbrain dopamine neurons 1.446
Cocaine, morphine and the cannabinoid win55212 depress neuronal activity in the rostromedial tegmental nucleus 1.419
Inhibition of anandamide hydrolysis differentially modulates cocaine-induced effects on rat mesolimbic system 1.417
Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation 1.389
Inhibition of anandamide hydrolysis antagonizes nicotine effects on neurons in the nucleus accumbens shell in the rat 1.372
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.362
Peroxisome proliferator activated receptors type alpha modulate nicotine effects in the rat ventral tegmental area 1.349
Neurobiological mechanisms of cannabinoid addiction 1.284
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia 1.263
Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1-and non-CB1-mediated actions 1.162
Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: Evidence for GABAB receptor-mediated effects 1.128
Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons 1.119
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 1.101
Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo 1.093
Endocannabinoids and the processing of value-related signals 1.082
Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors 1.060
Involvement of the endogenus cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: Electrophysiological evidence in vivo 1.036
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 1.025
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 1.016
Endocannabinoid-Like Lipid Neuromodulators in the Regulation of Dopamine Signaling: Relevance for Drug Addiction 943
Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex 911
Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology 903
null 850
Dietary Phospholipid-Bound Conjugated Linoleic Acid and Docosahexaenoic Acid Incorporation Into Fetal Liver and Brain Modulates Fatty Acid and N-Acylethanolamine Profiles 847
null 841
Medial forebrain bundle stimulation induces changes in dopamine neuron activity: role of endocannabinoids and glutamate 838
N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance 827
From surface to nuclear receptors: the endocannabinoid family extends its assets 807
null 800
Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal 776
Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors 762
Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate (GHB) receptor in the rat brain 756
null 747
Repurposing peroxisome proliferator-activated receptor agonists in neurological and psychiatric disorders 738
Endocannabinoid signalling in midbrain dopamine neurons: more than physiology? 733
Identification of metabolic biomarkers of chronic vagus nerve stimulation (VNS) in subjects with drug-resistant epilepsy (DRE) 732
Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation 717
Reinstatement of synaptic plasticity in the aging brain through specific dopamine transporter inhibition 715
PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings. 706
Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system 702
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy 699
The R100Q mutation of the GABA(A) alpha(6) receptor subunit may contribute to voluntary aversion to ethanol in the sNP rat line 654
Braking Dopamine Systems: A New GABA Master Structure for Mesolimbic and Nigrostriatal Functions 648
Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study 606
Cognitive performance in aged rats is associated with differences in distinctive neuronal populations in the ventral tegmental area and altered synaptic plasticity in the hippocampus 583
Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPARα Agonist Fenofibrate-Treated Mice 582
Transgenerational Sex-dependent Disruption of Dopamine Function Induced by Maternal Immune Activation 582
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring 561
Chronic administration of l-sulpiride at low doses reduces A10 but not A9 somatodentritic dopamine autoreceptor sensitivity 511
Totale 198.328
Salva come PNG Salva come JPEG
Categoria #
all - tutte 264.421
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 264.421
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.016 0 0 0 0 0 0 0 0 0 1.933 2.021 1.062
2021/202211.101 1.050 879 586 682 1.013 908 564 469 602 1.328 1.738 1.282
2022/202314.067 990 1.397 1.327 1.089 1.323 1.647 733 1.299 1.120 1.051 1.430 661
2023/202449.892 661 572 541 856 1.483 2.459 2.645 1.114 938 903 1.646 36.074
2024/202521.159 3.853 4.782 2.869 3.011 1.650 1.684 1.801 186 397 251 382 293
2025/20268.463 871 452 999 787 665 660 1.680 558 627 1.164 0 0
Totale 211.282